VOYG:NYSEVoyager Technologies, Inc. Analysis
Data as of 2026-09-01 - not real-time
$33.63
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Voyager Technologies, Inc. trades at $33.63, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. It has gained 34.7% over the past 30 days. RSI sits at 44.0, which reads as neutral, and MACD momentum is bearish. Price has been bracketed by support at $31.76 and resistance at $45.40.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 36.8% above where the shares trade now. Revenue is growing at 15.5% on a -78.6% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 100.1%, a beta of 3.44 and a maximum drawdown of 56.3%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 36.8% above where the shares trade now. Revenue is growing at 15.5% on a -78.6% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 100.1%, a beta of 3.44 and a maximum drawdown of 56.3%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.
Top Market Events
Voyager Technologies, Inc. NYSE: VOYG recently reported past second-quarter 2026 results with sales of US$52.75...Voyager Technologies NYSE: VOYG has been selected by Raytheon to provide solid controllable throttleable propulsion and...Voyager Technologies, Inc. VOYG delivered earnings and revenue surprises of +26.32% and +8.91%, respectively, for the...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 30.61
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 30.61
- Analyst targets imply +36.8% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- Negative profit margin of -78.6%
- Analyst targets imply +36.8% versus the current price
- Negative return on equity of -30.4%
Key Metrics & Analysis
Financial Health
Revenue Growth15.50%
Profit Margin-78.61%
P/E Ratio-21.1
ROE-30.44%
ROA-11.11%
Debt/Equity130.40
P/B Ratio5.6
Op. Cash Flow$-114067000
Free Cash Flow$-266253376
Industry P/E29.0
Technical Analysis
TrendBullish
RSI44.0
Support$31.76
Resistance$45.40
MA 20$38.66
MA 50$32.85
MA 200$30.61
MACDBearish
VolumeDecreasing
Fear & Greed Index94.36
Valuation
Target Price$46.00
Upside/Downside36.78%
GradeFair
TypeGrowth
Risk Assessment
Beta3.44
Volatility100.06%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.